Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients

Archives of Iranian Medicine

Volumn 13, Issue 6, 2010, Pages 469-475

  Zendehdel, Nasrin ^b   Massarrat, Sadegh ^a   Sheykholeslami, Arghavan ^a   Rakhshani, Naser ^a,c   Saeidi, Sandra ^d   Rafiee, Reza ^b   Nobakht, Hosein ^a   Tabib, Seyed Masoud ^a   Saliminejhad, Mehrdad ^a   Moghadam, Masoud Dooghaie ^a   Nasiri, Jafar ^a   Azimi, Kourosh ^a   Fakhar, Reza ^a   Babaei, Mehdi ^a   Didehvar, Reza ^a   Mohammadi, Nosratollah ^a   Tavazoee, Mehdi ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Familial; Gastric cancer; Gastritis; H. pylori

Indexed keywords

GASTRIN 17; PARIETAL CELL ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; ATROPHY; CANCER PATIENT; CANCER RISK; CELL INFILTRATION; DISEASE SEVERITY; DUODENUM ULCER; DYSPLASIA; ESOPHAGUS CANCER; FAMILY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INFECTION RATE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRECANCER; PREVALENCE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STOMACH; STOMACH ANTRUM; STOMACH BODY; STOMACH CANCER; STOMACH LESION; STOMACH MUCOSA; STOMACH ULCER;

ADULT; AGED; FAMILY; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 78649405787     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107: 113-118.
2. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12: 576-583.
3. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993; 72: 3174-3178.
4. Lehtola J. Family study of gastric carcinoma with special references to histological types Scand. J Gastroenterol Suppl. 1978; 50: 3-54.
5. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer. 1992; 70: 50-55.
6. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer. 1990; 66: 2047-2051.
7. Ogawa H, Kato I, Tominaga S. Family history of cancer among cancer patients. Jpn J Cancer Res. 1985; 76: 113-118.
8. Lissowska J, Groves FD, Sobin LH, Fraumeni JF Jr, Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev. 1999; 8: 223-227.
9. Meining A, Bayerdoerffer E, Mueller P, Miehlke S, Lehn N, et al. Gastric carcinoma risk index in patients infected with H. pylori. Virchows Arch. 1998; 432: 311-314.
10. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345: 784-789.
11. Ihamaeki TT, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Scand J Gastroenterol. 1979; 14: 801-812.
12. Meining A, Bayerdoerfer E, Stolte M. Helicobacter pylori gastritis of gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol. 1999; 11: 717-720.
13. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes of gastric cancer patients: critical role of H. pylori. Gastroenterology. 2000; 118: 22-30.
14. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer. 2002; 101: 469-474.
15. Sepulveda A, Peterson LE, Shelton J, Gutierrez O, Graham DY. Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol. 2002; 97: 1365-1370.
16. Rose NR, Burek CL. Autoimmune diseases, antibodies to tissue speci[1]c endocrine gastrointestinal and surface receptors. In: Rose NR, ed. Manual of Clinical Laboratory Immunology. 4th ed. Washington DC: ASM; 1992: 723-785.
17. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran populationbased cancer registry, 1998-2001. Arch Iran Med. 2009; 12: 15-23.
18. Kimura K. Chronological transition of fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology. 1972; 63: 584-592.
19. Dixon FM, Genta RM, Yardley JH, Correa P. Classification and Grading of Gastritis. The updated Sydney System and the participants in the International Workshop on the Histopathology of gastritis, Houston 1996. Am J Surg Path. 1996; 20: 1161-1181.
20. Konjetzny EG. Der Magenkrebs, Ferdinand Enke Verlag, Stuttgart, 1938: 136.
21. Morson BC. Intestinal metaplasia of gastric mucosa. Br J Cancer. 1955; 9: 365-376.
22. Du Plessis DJ. The distribution of gastritis in carcinoma of stomach. Br J Surg. 1974; 61: 521-524.
23. Skinner JM, Heenan P, Whitehead R. Atrophic gastritis in gastrectomy specimens. Br J Surg. 1975; 62: 23-32.
24. Reynolds KW, Johnson AG, Fox B. Is intestinal metaplasia of the gastric mucosa a premalignant lesion? Clin Oncol. 1975; 1: 101-109.
25. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992; 52: 6735-6740.
26. Massarrat S, Paidlik A, Pittner P, Scmitz-Moorman P, Wurbs M. The role of certain habits and various diseases in the occurrence of gastritis. Hepatogastroenterology. 1983; 30: 249-253.
27. Villako K, Tamm A, Savisaar E, Ruttas M. Is intestinal metaplasia of the gastric mucosa a premalignant lesion? Scand J Gastroenterol. 1976; 11: 817-822.
28. Petersson F, Borch K, Franzén LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol. 2002; 37: 262-266.
29. De Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut. 2007; 56: 1665-1670.
30. Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol. 2008; 6: 174-179.